Form 4: Confluent Executive Erica Schultz Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Confluent's President of Field Operations, Erica Schultz, executed a sale of 63,729 Class A common stock shares as part of a pre-arranged 10b5-1 trading plan.

Summary

  • Erica Schultz, President of Field Operations at Confluent, sold 63,729 shares of Class A Common Stock on November 26, 2024.
  • The sale was executed under a pre-arranged 10b5-1 trading plan established on August 15, 2024.
  • The shares were sold at prices ranging from $31.27 to $32.01, with a weighted average price of $31.6.
  • Following the transaction, Ms. Schultz directly owns 678,016 shares of Class A Common Stock.
  • She also indirectly owns shares through various trusts, including The Schultz Family Irrevocable Remainder Trust, The Bryan and Erica Schultz Family Revocable Trust, the Erica Schultz 2023 Annuity Trust, and The Schultz Family 2021 Irrevocable Beholder Trust.
  • Ms. Schultz also exercised stock options to acquire 63,729 shares of Class B Common Stock, which were then converted to Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, with no indication of positive or negative sentiment.

Risks

  • Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Executive stock sales are a common occurrence, especially under pre-arranged trading plans like 10b5-1, and are often viewed as part of normal executive compensation and financial planning.

Comparison to Industry Standards

  • The use of 10b5-1 trading plans is a standard practice among public company executives to avoid accusations of insider trading.
  • The sale of shares by executives is a common occurrence and is not unusual in the tech industry.
  • The reported transaction is consistent with standard SEC reporting requirements for insider trading.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial health.

Key Dates

DateDescription
08/15/2024Date of the 10b5-1 trading plan.
11/26/2024Date of the stock sale and option exercise.
11/27/2024Date the Form 4 was signed.
12/04/2029Expiration date of the stock options.

Keywords

insider trading, Form 4, stock sale, 10b5-1 plan, executive, Confluent, CFLT, Erica Schultz, Class A Common Stock, stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.